Peking University International Hospital Group Southwest Synthetic Pharmaceutical Co., Ltd. (stock abbreviation: Southwest synthesis; stock code: 000 788), located in Chongqing, China, is western China's largest biological and synthetic drugs production, development and export base in China of key pharmaceutical companies, national innovation pilot enterprises, hi-tech enterprise of national Torch Program, focusing on the export of Chongqing, best-selling brands, the world's largest Luo production base atorvastatin and sulfa drug production base. In 2009 the implementation of the private placement, Daxin Pharmaceutical Co., Ltd. quality assets into the Southwest synthesis, to achieve powerful combination, our strength.
Southwest Synthetic Pharmaceutical has a number of large manufacturing base, including cGMP by the construction of the international high standard two rivers in Chongqing City, a modern pharmaceutical manufacturing base, product categories covered by anti-microbial, cardiovascular category, vitamins, analgesic anti-inflammatory class, the digestive system class, class of mental disorders, anti-tumor, immune class, generation of plasma category, nearly 20 categories, more than one hundred varieties of bulk drugs and formulations.
Southwest synthesis is certified by the International one of the largest pharmaceutical companies in China, all products have passed the GMP certification, which There are 20 products the U.S. DMF registration number, FDA approved 12 products, 7 products have European COS certificate.
Southwest has a state-level synthesis technology center dedicated to innovative drugs, including new products, new technology and advanced production technology development and promotion, a number of senior professional and technical personnel enjoy special government allowances.
"ASD Operations integrate industry resources, integration of scientific and technological innovation of Chinese wisdom," relying on the North, continuous innovation, the future of Southwest will focus on promoting the synthesis, pharmaceutical assets to achieve full integration into international strategic partners, to build green manufacturing base in Chongqing, the introduction of a fist core products, establish the Southwest Synthetic (000 788) in the pharmaceutical industry's leading position in China, Chinese medicine to create a world brand.
